Medpace Holdings Inc
$ 520.00
3.74%
14 Apr - close price
- Market Cap 14,314,147,000 USD
- Current Price $ 520.00
- High / Low $ 520.36 / 501.25
- Stock P/E 32.76
- Book Value 16.18
- EPS 15.30
- Next Earning Report 2026-04-22
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.16 %
- ROE 0.70 %
- 52 Week High 628.92
- 52 Week Low 250.05
About
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.
Analyst Target Price
$500.08
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-09 | 2025-10-22 | 2025-07-21 | 2025-04-21 | 2025-02-10 | 2024-10-21 | 2024-07-22 | 2024-04-22 | 2024-02-12 | 2023-10-23 | 2023-07-24 | 2023-04-24 |
| Reported EPS | 4.67 | 3.86 | 3.103 | 3.67 | 3.6813 | 3.01 | 2.75 | 3.2 | 2.46 | 2.22 | 1.93 | 2.27 |
| Estimated EPS | 4.18 | 3.53 | 2.99 | 3.0775 | 3.1167 | 2.78 | 2.54 | 2.47 | 2.22 | 2.05 | 1.91 | 1.8 |
| Surprise | 0.49 | 0.33 | 0.113 | 0.5925 | 0.5646 | 0.23 | 0.21 | 0.73 | 0.24 | 0.17 | 0.02 | 0.47 |
| Surprise Percentage | 11.7225% | 9.3484% | 3.7793% | 19.2526% | 18.1153% | 8.2734% | 8.2677% | 29.5547% | 10.8108% | 8.2927% | 1.0471% | 26.1111% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-22 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 3.74 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MEDP
2026-04-14 15:38:53
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP) and its officers. The lawsuit claims that Medpace made false and misleading statements regarding its book-to-bill ratio between April 22, 2025, and February 9, 2026, leading to investor harm. Investors who purchased Medpace securities during this period are encouraged to join the case, with a lead plaintiff deadline of June 5, 2026.
2026-04-14 09:33:00
A class action lawsuit has been filed against Medpace Holdings, Inc. (NASDAQ: MEDP) for alleged violations of federal securities laws, claiming the company made false and misleading statements about its business performance between April 2025 and February 2026. The lawsuit highlights the importance of transparency in public company disclosures and seeks to recover losses for affected shareholders. DJS Law Group is representing the investors, with a deadline of June 5, 2026, for shareholders to join the case.
2026-04-14 05:41:00
The Schall Law Firm has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP) for alleged securities fraud. Investors who purchased Medpace securities between April 22, 2025, and February 9, 2026, are encouraged to contact the firm before June 5, 2026, to potentially lead the lawsuit. The complaint alleges that Medpace made false and misleading statements, leading to artificial inflation of its share price and investor damages.
2026-04-13 19:10:15
Levi & Korsinsky, LLP is notifying investors of Medpace Holdings, Inc. (NASDAQ: MEDP) about a class action securities lawsuit. The lawsuit alleges that Medpace made false and misleading statements regarding its backlog cancellation rate and growth expectations, leading to a significant stock price decline on February 10, 2026. Investors who suffered losses during a specific period are encouraged to contact the firm to discuss their rights as lead plaintiff before June 8, 2026.
2026-04-13 14:00:00
Shareholders of Medpace Holdings, Inc. (MEDP) who experienced losses are urged to contact the Law Offices of Howard G. Smith regarding a securities fraud lawsuit. The lawsuit alleges that Medpace made false and misleading statements between April 22, 2025, and February 9, 2026, particularly concerning its projected book-to-bill ratio and the impact of backlog cancellations. Investors have until June 8, 2026, to file a lead plaintiff motion.
2026-04-13 12:10:15
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP) and certain officers, alleging violations of federal securities laws. The lawsuit claims that Medpace made false and misleading statements about its book-to-bill ratio between April 22, 2025, and February 9, 2026. Investors who suffered losses during this period have until June 5, 2026, to seek to be appointed as lead plaintiff.
